FDA Rejects EUA Request For Monoclonal Antibody As COVID-19 Treatment

Reuters (9/9, Bhalla) reports the FDA “declined Humanigen Inc’s request for emergency use authorization (EUA) of its lenzilumab drug to treat newly hospitalized COVID-19 patients, the company said on Thursday.” In a statement, Humanigen said, “In its lett...